drug protocol number

D967RC00001

drug sponsor

Astrazeneca

drug study

Trastuzumab-deruxtecan

drug trial site

International Medical Center (Jeddah),King Fahad Specialist Hospital (Dammam)

drug status

Ongoing

drug phase